e-Drug3D

660

HALOBETASOL PROPIONATE


INN
HALOBETASOL PROPIONATE

(has an active metabolite)

cas 66852-54-8
CLASS

DERMATOLOGICAL
ANTI-INFLAMMATORY AGENTS
VASOCONSTRICTOR AGENTS
CORTICOSTEROIDS
ANTIPRURITIC

ROUTE (list)

TOPICAL

ATC code

D05AX55
D07AC21

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET GLUCOCORTICOID RECEPTOR

DrugCentral

Glucocorticoid receptor UNIPROT P04150 NR3C1

Download SDF file [(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate

Formula:
C25H31ClF2O5

Calculated chemical properties:

MW 484.95
NB_atoms 33
XLogP 4.05
PSA 60.33
NB_HD 1
NB_HA 5
fsp3 0.72
Lipinski(0=no;1=yes) 1

FDA
NDA 019967 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1990 DISCONTINUED
NDA 019968 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1990 NEWMOLECULARENTITY DISCONTINUED
NDA 076872 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2004
NDA 076903 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (FOUGERA PHARMS) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 076994 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (TARO) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 077001 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (FOUGERA PHARMS) APPROVAL= AP YEAR= 2004
NDA 077123 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2004
NDA 077109 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2005
NDA 077227 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (TARO) APPROVAL= AP YEAR= 2005 DISCONTINUED
NDA 077721 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 078162 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (COSETTE) APPROVAL= AP YEAR= 2007
NDA 208183 (pdf not found) INN (HALOBETASOL PROPIONATE) ULTRAVATE (LACER PHARMA) APPROVAL= AP YEAR= 2015
NDA 209978 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (ENCUBE) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 210566 (pdf not found) INN (HALOBETASOL PROPIONATE) LEXETTE (MAYNE PHARMA) APPROVAL= AP YEAR= 2018
NDA 209355 (pdf not found) INN (HALOBETASOL PROPIONATE) BRYHALI (BAUSCH) APPROVAL= AP YEAR= 2018
NDA 209354 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) DUOBRII (BAUSCH) APPROVAL= AP YEAR= 2019
NDA 211464 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 213560 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (QUAGEN) APPROVAL= AP YEAR= 2020
NDA 215266 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2023
NDA 214285 (pdf not found) INN (HALOBETASOL PROPIONATE) HALOBETASOL PROPIONATE (PERRIGO ISRAEL) APPROVAL= TA YEAR= 2023
NDA 217190 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) HALOBETASOL PROPIONATE AND TAZAROTENE (TARO) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL